ABOUT US | CONTACT | IAPAC HOME 
 

ATLIS 2010 HOME

ABOUT ATLIS 2008

ATLIS 2008 PRESS RELEASE

ATLIS 2008 KEY FINDINGS

ATLIS FINDINGS

GENERAL HEALTH STATUS

CURRENT AND FUTURE MEDICATIONS

PRIORITIES FOR FUTURE MEDICATIONS

CONCERNS ABOUT HIV STATUS

CURRENT SEX PRACTICES

Most desired traits in future HIV medications
(Ranked from 1 to 7, lower average rank indicates a higher desire)
(click here to downlaod PDF tables)

Region

Country

Easier to take

Help
me live
longer

Fewer side effects

More affordable

Attack virus in
new
way

Would
not have
to take
for rest
of life

Better access

 

 

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Average Rank

Western Europe
and USA

France

4.4

2.8

3.4

5.5

3.8

3.3

4.8

Germany

4.8

2.1

3.2

5.3

3.9

3.7

5.0

Italy

3.7

2.0

2.9

5.5

4.6

3.6

5.7

Spain

3.4

2.2

2.6

5.6

3.8

5.5

5.0

USA

4.9

2.9

3.8

4.5

4.0

2.9

5.1

Latin America

Caribbean

3.2

3.1

3.5

4.3

4.6

4.3

5.0

Mexico

4.0

2.9

3.6

4.3

4.7

4.1

4.5

Argentina

4.1

2.7

3.2

5.7

4.0

3.8

4.6

Brazil

3.9

2.8

3.3

5.3

4.5

3.4

4.9

South Africa, Russia, Asia/
Pacific

South Africa

3.9

2.9

3.8

4.8

4.0

3.8

4.8

Russia

3.4

2.9

3.1

5.4

4.5

3.1

5.6

Korea

3.8

3.8

3.7

4.7

4.6

2.4

5.1

Malaysia

4.4

3.8

4.0

4.9

3.9

3.3

3.7

New Zealand

4.5

3.2

3.6

5.3

3.9

3.4

4.1

 
line
©2011 International Association of Physicians in AIDS Care. All Rights Reserved.